BCRX vs BLTE Stock Comparison
BLTE currently leads BCRX in this stock comparison, with AIQ scores of 74 vs 59. The clearest difference is momentum.
What is the main difference between BCRX and BLTE?
BLTE leads the current stock comparison as Belite Bio, Inc, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
BioCryst Pharmaceuticals, Inc. vs Belite Bio, Inc
BLTE leads
BLTE leads by 15 AIQ points, primarily on Momentum and Quality, and the lead has widened from 12 points over 30 sessions.
Stable: 5 of 5 evidence groups support BLTE, its lead is widening, and its current signal state is conflicted.
BioCryst Pharmaceuticals, Inc.
Belite Bio, Inc
The Algovestiq AIQ Score currently favors BLTE over BCRX, 74 versus 59 as of Nov 15, 2026. BLTE's advantage is driven primarily by stronger momentum and quality. BLTE also shows the stronger technical structure relative to its 50-day moving average. 5 of 5 covered evidence groups favor BLTE today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. BLTE lead: Strengthening — the AIQ differential moved from 12 to 15 points over 30 sessions.
Compare BioCryst Pharmaceuticals, Inc. and Belite Bio, Inc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare BCRX and BLTE against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum42 vs 71BLTE +29
- Quality64 vs 85BLTE +21
- Risk Resilience55 vs 60BLTE +5
5 of 5 evidence groups favor BLTE. BLTE’s edge is concentrated in momentum and quality.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Momentum +4
New signals
- RSI Bearish Divergence — bearish, momentum, medium horizon
BLTE's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BCRX and BLTE both carry a full feed there.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BLTEBLTE on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BLTEBLTE on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
BLTEBLTE on the Momentum factor, by 29 points.
Lower downside
BLTEBLTE on Risk Resilience, by 5 points.
Analyst upside
BLTEBLTE on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BCRX | BLTE | Note |
|---|---|---|---|
| Implied upside to target | +44.5% | +58.6% | BLTE has more room |
| Target dispersion | 0% | +26.5% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 9 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 5 covered evidence groups favor BLTE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | BLTE | 59 vs 74 |
| Fundamentals | BLTE | EPS growth -51.6% vs -5.6% |
| Valuation | Not covered | Not covered |
| Technicals | BLTE | Price vs 50-day -7.6% vs 2.2%; vs 200-day -13.5% vs 2.7% |
| Risk Resilience | BLTE | Risk Resilience 55 vs 60 |
| Analyst expectations | BLTE | Target upside 44.5% vs 58.6% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BCRX and BLTE and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 15 points. (supports the conclusion holding)
- 5 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BLTE.
How the comparison changed
45 daily snapshots · Sep 14 – Nov 13BLTE lead: Strengthening — the AIQ differential moved from 12 to 15 points over 30 sessions.
- Today
- BLTE +15
- 59 vs 74
- 7 sessions ago
- BLTE +10
- 62 vs 72
- 30 sessions ago
- BLTE +12
- 60 vs 72
- 90 sessions ago
- Not covered
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 2 bearish / 2 neutral
Only BCRX
- Death Cross Active — bearish, trend, long horizon (6.91%)
- ADX Trend Weakening — neutral, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
5 bullish / 1 bearish / 1 neutral, conflicted
Only BLTE
- Golden Cross Active — bullish, trend, long horizon (0.48%)
- Accumulation Pattern — bullish, volume, medium horizon (1.24x)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
BLTE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -3.3%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BCRX closes the Momentum gap — currently 29 points behind, the largest single contributor to BLTE's edge.
- 2BCRX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3BLTE's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BLTE leads on balance| Metric | BCRX | BLTE |
|---|---|---|
| Revenue growth (YoY) | -17.4% | 0% |
| EPS growth (YoY) | -51.6% | -5.6% |
| Gross margin | 25.3% | 0% |
| Operating margin | -30.1% | 0% |
| Return on equity (TTM) | -9.5% | 0% |
| Debt to equity | -2.08 | 0 |
Performance
BLTE leads 6 of 6 windows| Metric | BCRX | BLTE |
|---|---|---|
| 1 week (5 sessions) | -1% | 6.6% |
| 1 month (20 sessions) | -2.3% | 15.1% |
| 3 months (63 sessions) | -23.4% | 0.7% |
| 6 months (126 sessions) | -15.6% | 14.9% |
| Year to date | -2.4% | 2.7% |
| 1 year (252 sessions) | 6% | 48.3% |
Technicals
BLTE has the stronger structure| Metric | BCRX | BLTE |
|---|---|---|
| RSI (14) | 40.7 | 57.3 |
| ADX (14) | 15.2 | 19.3 |
| Price vs 50-day | -7.6% | 2.2% |
| Price vs 200-day | -13.5% | 2.7% |
| Volatility (1M, annualized) | 45.2% | 59% |
Risk
BLTE is the more resilient| Metric | BCRX | BLTE |
|---|---|---|
| Beta | 0.65 | 1.05 |
| Sharpe ratio | 0.36 | 0.9 |
| Sortino ratio | 0.56 | 1.46 |
| Max drawdown | -32.2% | -29.1% |
| Current drawdown | -31.5% | -15.1% |
| Annualized volatility | 48.1% | 53.7% |
| Value at risk (95%) | -4.1% | -4.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BCRX or BLTE?
On the Algovestiq AIQ Score, BLTE is the stronger of the two as of Nov 15, 2026, scoring 74 against BCRX's 59. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BCRX or BLTE the better buy right now?
BLTE carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor BLTE over BCRX?
The composite weights Quality, Value, Momentum and Risk Resilience. BLTE leads Momentum by 29 points; BLTE leads Quality by 21 points; BLTE leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BCRX or BLTE?
Analyst price targets imply +44.5% upside for BCRX and +58.6% for BLTE, so the Street currently favors BLTE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BCRX or BLTE?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BCRX or BLTE?
BLTE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BCRX or BLTE?
BLTE on the Momentum factor, by 29 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BCRX or BLTE?
BLTE is the more resilient of the two, so the other name carries the higher downside risk. BLTE on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BCRX more profitable than BLTE?
Margin data is not comparable for both names in the current snapshot.
Is BLTE's lead over BCRX getting stronger or weaker?
BLTE lead: Strengthening — the AIQ differential moved from 12 to 15 points over 30 sessions. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has not changed hands in that window.
What would change the BCRX vs BLTE verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BCRX closes the Momentum gap — currently 29 points behind, the largest single contributor to BLTE's edge; BCRX's Death Cross Active resolves — a bearish trend rule currently active against it; BLTE's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about BCRX and BLTE?
BCRX: 0 bullish / 2 bearish / 2 neutral. BLTE: 5 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BCRX is Death Cross Active (bearish, long horizon). On BLTE it is Golden Cross Active (bullish, long horizon).
Compare BCRX and BLTE with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.